JDRF International joins community and clinical partners to improve type 1 diabetes care in India

13 December 2023 | News

A cornerstone of the partnership's strategy is the collaborative work undertaken with clinical communities across India

image credit- shutterstock

image credit- shutterstock

JDRF International, the leading global type 1 diabetes (T1D) research and advocacy organisation, in partnership with the community, clinical partners and William J. Clinton Foundation (WJCF), an affiliate of the Clinton Health Access Initiative in India, has announced a sweeping set of collaborations that aims to drastically improve T1D care.

The efforts include supporting public health programmes, innovative grassroots initiatives, and dedicated clinician networks converging to create a multi-dimensional strategy to tackle T1D.

Ensuring that essential social and educational needs are met, all partners will work in concert to promote more effective diabetes management for people living with T1D in India. Healthcare professionals will pledge to promote basic care that involves a multiple daily injection insulin regimen and regular glucose monitoring. This initiative aims to create a synergy between medical experts and peer groups, fostering a cooperative environment where clinical knowledge meets community wisdom.

According to the T1D Index, a first of its kind data simulation tool that measures the human and public health impact of type 1 diabetes, India has the largest "missing" prevalence of type 1 diabetes in the world. Increasing focus on screening for diagnosing T1D and helping manage care will improve longevity and quality of life for them. 

As part of this process, the government of India has initiated several comprehensive programmes that address immediate health care needs and pave the way for long-term systemic improvements in T1D care.  Several Indian states are at the forefront, with significant T1D programs, serving as models of innovation and effectiveness and select states will be served by the support currently being developed in partnership with JDRF International, William J. Clinton Foundation, The Helmsley Charitable Trust with support from Eli Lilly and Company. 



× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account